These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37234261)
1. Validation of a pharmacological imaging challenge using Soyer A; Leterrier S; Breuil L; Goislard M; Leroy C; Saba W; Thibault K; Bo GD; Bottlaender M; Caillé F; Goutal S; Tournier N Front Neurosci; 2023; 17():1181786. PubMed ID: 37234261 [TBL] [Abstract][Full Text] [Related]
2. Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study. Seah S; Asad AB; Baumgartner R; Feng D; Williams DS; Manigbas E; Beaver JD; Reese T; Henry B; Evelhoch JL; Chin CL PLoS One; 2014; 9(10):e110432. PubMed ID: 25337714 [TBL] [Abstract][Full Text] [Related]
3. Effects of isoflurane anesthesia and intravenous morphine self-administration on regional glucose metabolism ([ Park TY; Nishida KS; Wilson CM; Jaiswal S; Scott J; Hoy AR; Selwyn RG; Dardzinski BJ; Choi KH Eur J Neurosci; 2017 Apr; 45(7):922-931. PubMed ID: 28196306 [TBL] [Abstract][Full Text] [Related]
4. Impact of Donepezil on Brain Glucose Metabolism Assessed Using [ Hugon G; Goutal S; Sarazin M; Bottlaender M; Caillé F; Droguerre M; Charvériat M; Winkeler A; Tournier N Front Neurosci; 2022; 16():835577. PubMed ID: 35281502 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo. Auvity S; Goutal S; Caillé F; Vodovar D; Pruvost A; Wimberley C; Leroy C; Tonietto M; Bottlaender M; Tournier N Neuropsychopharmacology; 2021 May; 46(6):1220-1228. PubMed ID: 33603137 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of [3H]-buprenorphine in the rat. Holland MJ; Carr KD; Simon EJ Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):3-16. PubMed ID: 2546225 [TBL] [Abstract][Full Text] [Related]
15. Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals. Patel VD; Lee DE; Alexoff DL; Dewey SL; Schiffer WK Neuroimage; 2008 Jul; 41(3):1051-66. PubMed ID: 18442926 [TBL] [Abstract][Full Text] [Related]
16. Brain PET imaging using Auvity S; Vodovar D; Goutal S; Cisternino S; Chevillard L; Soyer A; Bottlaender M; Caillé F; Mégarbane B; Tournier N J Cereb Blood Flow Metab; 2024 Mar; 44(3):449-458. PubMed ID: 38097513 [TBL] [Abstract][Full Text] [Related]
17. Comparison of: (2 Miner MWG; Liljenbäck H; Virta J; Helin S; Eskola O; Elo P; Teuho J; Seppälä K; Oikonen V; Yang G; Kindler-Röhrborn A; Minn H; Li XG; Roivainen A Front Oncol; 2021; 11():730358. PubMed ID: 34692505 [TBL] [Abstract][Full Text] [Related]
18. Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [ Liu J; Yu J; Liu HB; Yao Q; Zhang Y Ann Nucl Med; 2022 Dec; 36(12):1019-1030. PubMed ID: 36178570 [TBL] [Abstract][Full Text] [Related]
19. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [ Bajorat R; Kurth J; Stenzel J; Vollmar B; Krause BJ; Reuter DA; Schuerholz T; Bergt S Mol Imaging Biol; 2022 Jun; 24(3):466-478. PubMed ID: 34779968 [TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease. Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]